Reading ATRA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRA free→Reading ATRA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRA free→QuarterlyIQ Insights · ATRA
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 11, 2026, the Board of Directors (the “ Board ”) of Atara Biotherapeutics, Inc. (the “ Company ”) appointed Brian Cherry to serve as a member of the Board as a Class I director, effective June 11, 2026 (the “ Effective Date ”). Mr. Cherry was also appointed to the Audit Committee of the Board. The Board has determined that Mr. Cherry is ind…
Importance-ranked changes since the prior daily snapshot.
Valuation label changed from 'None' to 'inexpensive'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.